These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15046539)

  • 1. Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis.
    Leon AC
    J Clin Psychiatry; 2004; 65 Suppl 4():31-6. PubMed ID: 15046539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ideal trial to test differential onset of antidepressant effect.
    Leon AC; Blier P; Culpepper L; Gorman JM; Hirschfeld RM; Nierenberg AA; Roose SP; Rosenbaum JF; Stahl SM; Trivedi MH
    J Clin Psychiatry; 2001; 62 Suppl 4():34-6; discussion 37-40. PubMed ID: 11229787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of newer antidepressant].
    Inada K
    Nihon Rinsho; 2007 Sep; 65(9):1645-9. PubMed ID: 17876988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECT versus tricyclic antidepressants in depression: a review of the evidence.
    Rifkin A
    J Clin Psychiatry; 1988 Jan; 49(1):3-7. PubMed ID: 3275634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study designs and outcomes in antidepressant clinical trials.
    Khan A; Schwartz K
    Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology to measure onset of action.
    Thase ME
    J Clin Psychiatry; 2001; 62 Suppl 15():18-21. PubMed ID: 11444762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled studies in depression: necessary, ethical and feasible.
    Baldwin D; Broich K; Fritze J; Kasper S; Westenberg H; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):22-8. PubMed ID: 12664309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs.
    Santen G; Horrigan J; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2009 Sep; 86(3):255-62. PubMed ID: 19675543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities.
    Baghai TC; Volz HP; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):198-222. PubMed ID: 17071541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are 2-week trials sufficient to indicate efficacy?
    Montgomery SA
    Psychopharmacol Bull; 1995; 31(1):41-4. PubMed ID: 7675988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
    Emslie GJ; Ryan ND; Wagner KD
    J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for producing faster acting antidepressants.
    Adell A; Castro E; Celada P; Bortolozzi A; Pazos A; Artigas F
    Drug Discov Today; 2005 Apr; 10(8):578-85. PubMed ID: 15837601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional assessment of acute and long-term effects in antidepressant drug trials.
    Müller-Oerlinghausen B
    Pharmacopsychiatry; 1994 Jul; 27 Suppl 1():18-20. PubMed ID: 7984692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring onset of antidepressant action in clinical trials: an overview of definitions and methodology.
    Leon AC
    J Clin Psychiatry; 2001; 62 Suppl 4():12-6; discussion 37-40. PubMed ID: 11229782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research and methodological issues for evaluating the therapeutic effectiveness of antidepressant drugs.
    Prien RF; Levine J
    Psychopharmacol Bull; 1984; 20(2):250-7. PubMed ID: 6374721
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamics of the dopaminergic system as a key component to the understanding of depression.
    Yadid G; Friedman A
    Prog Brain Res; 2008; 172():265-86. PubMed ID: 18772037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological approach to failures of antidepressant treatment].
    Rogue P
    Encephale; 1998; 24(6):575-80. PubMed ID: 9949941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.